# FDA Inspection 1001737 - Amneal Pharmaceuticals LLC - February 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/amneal-pharmaceuticals-llc/1b541003-9e82-4e10-ac62-9a9c8c6d5895
Source feed: FDA_Inspections

> FDA Inspection 1001737 for Amneal Pharmaceuticals LLC on February 21, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001737
- Company Name: Amneal Pharmaceuticals LLC
- Inspection Date: 2017-02-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1073966 - 2018-11-28](https://www.keypedia.com/records/fda_inspections/amneal-pharmaceuticals-llc/c4ceda46-d4c1-4f02-8ce4-9da90b146f43)
- [FDA Inspection 833538 - 2013-05-30](https://www.keypedia.com/records/fda_inspections/amneal-pharmaceuticals-llc/26009a2b-659c-4633-b10f-67724f693c0e)

Company: https://www.keypedia.com/companies/amneal-pharmaceuticals-llc/dfe28c99-faab-4039-90dc-5d5c55de1095

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c